Literature DB >> 8849583

Renal dopamine receptors: mechanisms of action and developmental aspects.

P Y Cheung1, K J Barrington.   

Abstract

Dopamine is important for renal perfusion, natriuresis, and the control of blood pressure. Modulation of the activities of adenylyl cyclase, phospholipase C and protein kinases is involved in the signal transduction pathway of dopamine. Peripheral dopamine receptors are classified as the DA1 and DA2 subtypes on the basis of synaptic localization and their pharmacological profiles. In the kidney, DA1 receptors are localized in the medial layer of the renal vasculature and along the nephron; DA2 receptors are found in the glomerulus and the nerves surrounding renal blood vessels. While DA1 receptor stimulation results in renal vasodilatation and natriuresis, DA2 receptors may play a synergistic role in the DA1 modulated natriuresis. There is increasing evidence that these effects of dopamine are attenuated in younger than in older animals. Future studies should be directed to identify the ontogenic differences in vascular and tubular dopamine receptors (density and affinity) and their coupling mechanisms, in order to evaluate the role of dopamine which is frequently used in the management of shock in newborns.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8849583

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN: 0008-6363            Impact factor:   10.787


  5 in total

1.  Effects of low-dose dopamine on urine output in normotensive very low birth weight neonates.

Authors:  J L Crouchley; P B Smith; C M Cotten; C D Hornik; R N Goldberg; J W Foreman; J L Wynn
Journal:  J Perinatol       Date:  2013-02-28       Impact factor: 2.521

Review 2.  Dopamine, kidney, and hypertension: studies in dopamine receptor knockout mice.

Authors:  Xiaoyan Wang; Van Anthony M Villar; Ines Armando; Gilbert M Eisner; Robin A Felder; Pedro A Jose
Journal:  Pediatr Nephrol       Date:  2008-07-10       Impact factor: 3.714

Review 3.  Dopamine versus no treatment to prevent renal dysfunction in indomethacin-treated preterm newborn infants.

Authors:  K Barrington; L P Brion
Journal:  Cochrane Database Syst Rev       Date:  2002

4.  The neuropharmacology of (-)-stepholidine and its potential applications.

Authors:  Kechun Yang; Guozhang Jin; Jie Wu
Journal:  Curr Neuropharmacol       Date:  2007-12       Impact factor: 7.363

Review 5.  Pharmacological Benefits and Risk of Using Hormones in Organ Perfusion and Preservation Solutions in the Aspect of Minimizing Hepatic Ischemia-Reperfusion Injury during Storage.

Authors:  Aneta Ostróżka-Cieślik; Barbara Dolińska
Journal:  Biomed Res Int       Date:  2019-11-11       Impact factor: 3.411

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.